316 related articles for article (PubMed ID: 15368430)
1. Telomeres and telomerase: a dual role in hepatocarcinogenesis.
Satyanarayana A; Manns MP; Rudolph KL
Hepatology; 2004 Aug; 40(2):276-83. PubMed ID: 15368430
[TBL] [Abstract][Full Text] [Related]
2. Telomeres and telomerase in aging, regeneration and cancer.
Djojosubroto MW; Choi YS; Lee HW; Rudolph KL
Mol Cells; 2003 Apr; 15(2):164-75. PubMed ID: 12803478
[TBL] [Abstract][Full Text] [Related]
3. Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
Lechel A; Holstege H; Begus Y; Schienke A; Kamino K; Lehmann U; Kubicka S; Schirmacher P; Jonkers J; Rudolph KL
Gastroenterology; 2007 Apr; 132(4):1465-75. PubMed ID: 17433324
[TBL] [Abstract][Full Text] [Related]
4. Contrasting effects of telomere shortening on organ homeostasis, tumor suppression, and survival during chronic liver damage.
Wiemann SU; Satyanarayana A; Buer J; Kamino K; Manns MP; Rudolph KL
Oncogene; 2005 Feb; 24(9):1501-9. PubMed ID: 15608677
[TBL] [Abstract][Full Text] [Related]
5. Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma.
Lechel A; Manns MP; Rudolph KL
J Hepatol; 2004 Sep; 41(3):491-7. PubMed ID: 15336455
[No Abstract] [Full Text] [Related]
6. Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression.
Farazi PA; Glickman J; Horner J; Depinho RA
Cancer Res; 2006 May; 66(9):4766-73. PubMed ID: 16651430
[TBL] [Abstract][Full Text] [Related]
7. Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma.
Djojosubroto MW; Chin AC; Go N; Schaetzlein S; Manns MP; Gryaznov S; Harley CB; Rudolph KL
Hepatology; 2005 Nov; 42(5):1127-36. PubMed ID: 16114043
[TBL] [Abstract][Full Text] [Related]
8. Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma.
Farazi PA; Glickman J; Jiang S; Yu A; Rudolph KL; DePinho RA
Cancer Res; 2003 Aug; 63(16):5021-7. PubMed ID: 12941829
[TBL] [Abstract][Full Text] [Related]
9. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
[TBL] [Abstract][Full Text] [Related]
11. Telomere length variation and maintenance in hepatocarcinogenesis.
Yokota T; Suda T; Igarashi M; Kuroiwa T; Waguri N; Kawai H; Mita Y; Aoyagi Y
Cancer; 2003 Jul; 98(1):110-8. PubMed ID: 12833463
[TBL] [Abstract][Full Text] [Related]
12. Absence of telomerase and shortened telomeres have minimal effects on skin and pancreatic carcinogenesis elicited by viral oncogenes.
Argilla D; Chin K; Singh M; Hodgson JG; Bosenberg M; de Solórzano CO; Lockett S; DePinho RA; Gray J; Hanahan D
Cancer Cell; 2004 Oct; 6(4):373-85. PubMed ID: 15488760
[TBL] [Abstract][Full Text] [Related]
13. Telomerase regulation and progressive telomere shortening of rat hepatic stem-like epithelial cells during in vitro aging.
Oh BK; Lee CH; Park C; Park YN
Exp Cell Res; 2004 Aug; 298(2):445-54. PubMed ID: 15265692
[TBL] [Abstract][Full Text] [Related]
14. Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis.
Begus-Nahrmann Y; Hartmann D; Kraus J; Eshraghi P; Scheffold A; Grieb M; Rasche V; Schirmacher P; Lee HW; Kestler HA; Lechel A; Rudolph KL
J Clin Invest; 2012 Jun; 122(6):2283-8. PubMed ID: 22622037
[TBL] [Abstract][Full Text] [Related]
15. Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis.
Hackett JA; Greider CW
Oncogene; 2002 Jan; 21(4):619-26. PubMed ID: 11850787
[TBL] [Abstract][Full Text] [Related]
16. [The correlation analysis of telomerase activity and aberrant expression of telomerase subunits during the progression of hepatocellular carcinoma].
Li BJ; Wang XH; Qu B
Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):311-2. PubMed ID: 15161518
[No Abstract] [Full Text] [Related]
17. Telomere instability and cancer.
Londoño-Vallejo JA
Biochimie; 2008 Jan; 90(1):73-82. PubMed ID: 17728038
[TBL] [Abstract][Full Text] [Related]
18. Telomere length homeostasis requires that telomerase levels are limiting.
Cristofari G; Lingner J
EMBO J; 2006 Feb; 25(3):565-74. PubMed ID: 16424902
[TBL] [Abstract][Full Text] [Related]
19. Telomerase RNA levels limit the telomere length equilibrium.
Greider CW
Cold Spring Harb Symp Quant Biol; 2006; 71():225-9. PubMed ID: 17381301
[TBL] [Abstract][Full Text] [Related]
20. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.
Miura N; Horikawa I; Nishimoto A; Ohmura H; Ito H; Hirohashi S; Shay JW; Oshimura M
Cancer Genet Cytogenet; 1997 Jan; 93(1):56-62. PubMed ID: 9062581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]